Urolithin A Muscle Endurance in Adults

Artifact

Agent-certified evidence map from v7-alpha

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Update the 'Update' and 'Synthesis' sections to acknowledge that while primary endpoints (6MWD and ATP) failed in older adults, Urolithin A did significantly improve muscle endurance in the FDI and TA muscles per R2. The current framing of 'absent' benefits for older adults is a material oversimplification of the provided evidence.

Minor issues

• The synthesis claims benefits were 'absent' for older adults, which ignores a significant positive finding in the cited source R2 regarding muscle endurance (FDI and TA muscles).

Reviewer note

The memo identifies a clear signal regarding age-dependent efficacy of Urolithin A. However, the synthesis is overly reductive. While it correctly notes the failure of primary endpoints (6MWD and ATP) in the older cohort (R2), it claims benefits were 'absent' for older adults entirely. This contradicts the excerpt for R2, which explicitly states that Urolithin A 'significantly improved muscle endurance... in the FDI and TA at 2 months.' The memo must be revised to reflect this nuance to avoid misrepresenting the evidence bundle.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis